These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 9538173)
1. Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer. Rizzo S Oncol Rep; 1998; 5(3):667-71. PubMed ID: 9538173 [TBL] [Abstract][Full Text] [Related]
2. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand. Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558 [TBL] [Abstract][Full Text] [Related]
3. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420 [TBL] [Abstract][Full Text] [Related]
4. [Multimodality therapy of late stage lung cancer]. Liao M; Zhao J; Zhou Y Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):384-6. PubMed ID: 8697983 [TBL] [Abstract][Full Text] [Related]
5. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer]. Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103 [TBL] [Abstract][Full Text] [Related]
7. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival. Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576 [TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients. Kappers I; Belderbos JS; Burgers JA; van Zandwijk N; Groen HJ; Klomp HM Lung Cancer; 2008 Mar; 59(3):385-90. PubMed ID: 17913281 [TBL] [Abstract][Full Text] [Related]
9. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967 [TBL] [Abstract][Full Text] [Related]
10. [Detection and prognostic significance of micrometastasis in peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation therapy]. Chen TF; Jiang GL; Zhang YQ; Wang LJ; Fu XL; Qian H; Wu KL; Zhao S Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):365-8. PubMed ID: 17892133 [TBL] [Abstract][Full Text] [Related]
11. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy. Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996 [TBL] [Abstract][Full Text] [Related]
12. [To be cured of lung cancer]. Depierre A; Jacoulet P; Westeel V; Falcoz PE Bull Cancer; 2002 Apr; 89(4):351-6. PubMed ID: 12016035 [TBL] [Abstract][Full Text] [Related]
13. [What is the value of neoadjuvant therapy in bronchial carcinoma?]. Digel W; Brethner L; Hasse J Zentralbl Chir; 2000; 125(4):315-8. PubMed ID: 10829310 [TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer. The role of chemoimmunoradiotherapy after surgery. Kshivets O J Exp Clin Cancer Res; 2001 Dec; 20(4):491-503. PubMed ID: 11876542 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ; J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657 [TBL] [Abstract][Full Text] [Related]
16. Subcategorization of resectable non-small cell lung cancer involving neighboring structures. Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135 [TBL] [Abstract][Full Text] [Related]
17. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739 [TBL] [Abstract][Full Text] [Related]
18. Arterial invasion predicts early mortality in stage I non-small cell lung cancer. Pechet TT; Carr SR; Collins JE; Cohn HE; Farber JL Ann Thorac Surg; 2004 Nov; 78(5):1748-53. PubMed ID: 15511466 [TBL] [Abstract][Full Text] [Related]
19. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer. Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799 [TBL] [Abstract][Full Text] [Related]
20. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]